{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:51:19Z","timestamp":1789041079868,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.lungcan.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T10:31:17Z","timestamp":1526380277000},"page":"76-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6533-5376","authenticated-orcid":false,"given":"C.C.H.J.","family":"Kuijpers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.E.L.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-M.C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.R.","family":"van Lindert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Damhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lungcan.2018.05.006_bib0005","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/annonc\/mdr489","article-title":"Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice","volume":"22","author":"Sequist","year":"2011","journal-title":"Ann. Oncol."},{"issue":"10026","key":"10.1016\/j.lungcan.2018.05.006_bib0010","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(16)00004-0","article-title":"Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)","volume":"387","author":"Barlesi","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"10","key":"10.1016\/j.lungcan.2018.05.006_bib0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.lungcan.2018.05.006_bib0020","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.lungcan.2018.05.006_bib0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/neuonc\/noq076","article-title":"EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer","volume":"12","author":"Eichler","year":"2010","journal-title":"Neuro-oncology"},{"issue":"5","key":"10.1016\/j.lungcan.2018.05.006_bib0030","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/JTO.0000000000000516","article-title":"Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: the lung cancer mutation consortium experience","volume":"10","author":"Sholl","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2018.05.006_bib0035","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/bjc.2016.182","article-title":"Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery","volume":"115","author":"Renaud","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2018.05.006_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-015-0714-8","article-title":"EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET\/CT scan","volume":"33","author":"Guan","year":"2016","journal-title":"Med. Oncol. (Northwood, London, England)"},{"issue":"1","key":"10.1016\/j.lungcan.2018.05.006_bib0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10585-016-9822-x","article-title":"Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China","volume":"34","author":"Li","year":"2017","journal-title":"Clin. Exp. Metastasis"},{"issue":"18","key":"10.1016\/j.lungcan.2018.05.006_bib0050","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1002\/cncr.27409","article-title":"Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer","volume":"118","author":"Doebele","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2018.05.006_bib0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.lungcan.2014.01.006","article-title":"EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?","volume":"84","author":"Hendriks","year":"2014","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"10.1016\/j.lungcan.2018.05.006_bib0060","unstructured":"S.S. Visser O, Dijck JAAM van (editors). Incidence of cancer in the Netherlands 1999\/2000, eleventh report of the Netherlands Cancer Registry., The Netherlands Cancer Registry (NCR),Vereniging van Integrale Kankercentra2003."},{"key":"10.1016\/j.lungcan.2018.05.006_bib0065","unstructured":"Dutch guideline Non-small cell lung cancer, 2015. http:\/\/www.oncoline.nl\/niet-kleincellig-longcarcinoom."},{"issue":"1","key":"10.1016\/j.lungcan.2018.05.006_bib0070","first-page":"19","article-title":"Pathology databanking and biobanking in The Netherlands a central role for PALGA, the nationwide histopathology and cytopathology data network and archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Cell. Oncol."},{"issue":"Suppl. 3","key":"10.1016\/j.lungcan.2018.05.006_bib0075","article-title":"Bone health in cancer patients: ESMO clinical practice guidelines","volume":"25","author":"Coleman","year":"2014","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2018.05.006_bib0080","first-page":"45","article-title":"Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations","volume":"59","author":"Nagata","year":"2013","journal-title":"Osaka City Med. J."},{"issue":"2","key":"10.1016\/j.lungcan.2018.05.006_bib0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jcp.21511","article-title":"Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling","volume":"217","author":"Yi","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lungcan.2018.05.006_bib0090","doi-asserted-by":"crossref","first-page":"42979","DOI":"10.1038\/srep42979","article-title":"Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.lungcan.2018.05.006_bib0095","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1183\/09031936.00167407","article-title":"Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma","volume":"32","author":"Wu","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lungcan.2018.05.006_bib0100","first-page":"756265","article-title":"Association of epidermal growth factor receptor mutations with metastatic presentations in non-small cell lung cancer","volume":"2011","author":"Na","year":"2011","journal-title":"ISRN Oncol."},{"key":"10.1016\/j.lungcan.2018.05.006_bib0105","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1038\/srep39721","article-title":"KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis","volume":"7","author":"Lohinai","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.lungcan.2018.05.006_bib0110","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/JTO.0000000000000673","article-title":"The IASLC lung cancer staging project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer","volume":"10","author":"Eberhardt","year":"2015","journal-title":"J. Thorac. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218303702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218303702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T14:20:15Z","timestamp":1534861215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218303702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":22,"alternative-id":["S0169500218303702"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.05.006","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}